 |
|
Mosquitoes vs. Malaria: How we can win the fight
March 22, 2004EMBL scientists have identified four mosquito proteins that affect the ability of the malaria parasite (Plasmodium) to survive and develop in the malaria-carrier mosquito (Anopheles). This breakthrough, featured in recent issues of Cell (March 5, 2004) and Science (March 26, 2004), could be used to block the transmission of malaria from mosquitoes to humans.
"Many researchers focus on the direct effects of Plasmodium on the human body but the mosquito is an equally important battleground in fighting the disease," notes Prof. Fotis C. Kafatos, EMBL's Director-General and leader of the group focusing on malaria research. "We now see a way to potentially stop the parasite in its tracks."
When a blood-feeding Anopheles mosquito bites an infected organism, the insect feeds on its blood - taking in the malaria-causing Plasmodium. After three weeks of developing within the mosquito, the Plasmodium moves from the insect gut into the salivary glands and is ready for transmission: at the next bloodmeal it will be injected into the bloodstream along with the mosquito's saliva, initiating a new infection cycle.
But one fact that had continued to puzzle malaria researchers is why within one mosquito species, some mosquitoes transmit malaria (termed "susceptible"), whereas others do not ("refractory"). It was suspected that protein factors of the mosquito's immune system might be responsible for this difference. EMBL scientists have now shown this to be the case - with a new twist.
Two of these mosquito proteins, TEP1 and LRIM1, were shown to be true defenders of the mosquito - killing the parasite in the insect's gut.
"The TEP1 and LRIM1 studies proved that the mosquito's immune system has the ability to defend itself against malaria. By enhancing these natural defenders, we may be able to block the parasite-mosquito cycle," says EMBL PhD student Stephanie Blandin, who worked on the TEP1 studies with CNRS researcher (and EMBL alumna) Elena Levashina and collaborators from the University of Leiden (The Netherlands).
"Our studies on TEP1 represent an important step because they show that TEP1 specifically locks onto the Plasmodium and it is this binding that mediates the killing of the parasite," notes Levashina. "Different forms of this protein are present in susceptible and refractory mosquitoes, potentially accounting for the fact that refractory mosquitoes do not sustain parasite development."
In the Kafatos Group, a collaboration between postdoctoral fellow Mike Osta and Staff Scientist George Christophides revealed a new twist: in addition to the mosquito defender protein LRIM1, they discovered two proteins, CTL4 and CTLMA2, which have an opposite effect, actually protecting the parasite as it develops in the mosquito gut. If these proteins were eliminated, the parasites died.
"It is now clear that if we strip away protective proteins, the parasite becomes vulnerable to the mosquito's immune system," Christophides notes. "Developing novel chemicals to inhibit the ability of such proteins to protect the parasite is a promising avenue to decrease the prevalence of malaria."
Prof. Kafatos agrees. "These studies are the first to show the power of the mosquito's immune system and give us some very real options for fighting the disease in the insect before it even has a chance to be passed to a human," he explains. "There is no single 'magic bullet' for controlling this ancient scourge of humanity, but we want to exploit this new lead to contribute to the defeat of malaria."
European Molecular Biology Laboratory (EMBL)
But one fact that had continued to puzzle malaria researchers is why within one mosquito species, some mosquitoes transmit malaria (termed "susceptible"), whereas others do not ("refractory"). It was suspected that protein factors of the mosquito's immune system might be responsible for this difference. EMBL scientists have now shown this to be the case - with a new twist.
Two of these mosquito proteins, TEP1 and LRIM1, were shown to be true defenders of the mosquito - killing the parasite in the insect's gut.
"The TEP1 and LRIM1 studies proved that the mosquito's immune system has the ability to defend itself against malaria. By enhancing these natural defenders, we may be able to block the parasite-mosquito cycle," says EMBL PhD student Stephanie Blandin, who worked on the TEP1 studies with CNRS researcher (and EMBL alumna) Elena Levashina and collaborators from the University of Leiden (The Netherlands).
"Our studies on TEP1 represent an important step because they show that TEP1 specifically locks onto the Plasmodium and it is this binding that mediates the killing of the parasite," notes Levashina. "Different forms of this protein are present in susceptible and refractory mosquitoes, potentially accounting for the fact that refractory mosquitoes do not sustain parasite development."
In the Kafatos Group, a collaboration between postdoctoral fellow Mike Osta and Staff Scientist George Christophides revealed a new twist: in addition to the mosquito defender protein LRIM1, they discovered two proteins, CTL4 and CTLMA2, which have an opposite effect, actually protecting the parasite as it develops in the mosquito gut. If these proteins were eliminated, the parasites died.
"It is now clear that if we strip away protective proteins, the parasite becomes vulnerable to the mosquito's immune system," Christophides notes. "Developing novel chemicals to inhibit the ability of such proteins to protect the parasite is a promising avenue to decrease the prevalence of malaria."
Prof. Kafatos agrees. "These studies are the first to show the power of the mosquito's immune system and give us some very real options for fighting the disease in the insect before it even has a chance to be passed to a human," he explains. "There is no single 'magic bullet' for controlling this ancient scourge of humanity, but we want to exploit this new lead to contribute to the defeat of malaria."
European Molecular Biology Laboratory (EMBL)
Malaria Current Events and Malaria News RSSMeasuring and modeling blood flow in malaria
When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells.
On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites.
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
Small nanoparticles bring big improvement to medical imaging
If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging.
Prioritizing low-cost, simple health measures would save 2.5 million child lives a year
Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes.
Drug industry, nonprofits join forces to fight world's neglected diseases
Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year.
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
DNA barcodes: Creative new uses span health, fraud, smuggling, history, more
The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others.
PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.
More Malaria Current Events and Malaria News Articles
 |
The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease) by Randall M. Packard (Author) Malaria sickens hundreds of millions of people -- and kills one to three million -- each year. Despite massive efforts to eradicate the disease, it remains a major public health problem in poorer tropical regions. But malaria has not always been concentrated in tropical areas. How did other regions control malaria and why does the disease still flourish in some parts of the globe? From Russia to Bengal to Palm Beach, Randall Packard's far-ranging narrative traces the natural and social forces that help malaria spread and make it deadly. He finds that war, land development, crumbling health systems, and globalization -- coupled with climate change and changes in the distribution and flow of water -- create conditions in which malaria's carrier mosquitoes thrive. The combination of... |
 |
The Malaria Capers : More Tales of Parasites and People, Research and Reality by Robert S. Desowitz (Author) "Reads like a murder mystery. . . . [Desowitz] writes with uncommon lucidity and verse, leaving the reader with a vivid understanding of malaria and other tropical diseases, and the ways in which culture, climate and politics have affected their spread and containment."—New York Times Why, Robert S. Desowitz asks, has biotechnical research on malaria produced so little when it had promised so much? An expert in tropical diseases, Desowtiz searches for answers in this provocative book. . |
 |
Compiled 1981-1984 by Malaria! |
 |
Humanity's Burden: A Global History of Malaria (Studies in Environment and History) by James L.A. Webb Jr. (Author) Humanity's Burden provides a panoramic overview of the history of malaria. It traces the long arc of malaria out of tropical Africa into Eurasia, its transfer to the Americas during the early years of the Columbian exchange, and its retraction from the middle latitudes into the tropics since the late nineteenth century. Adopting a broadly comparative approach to historical patterns and processes, it synthesizes research findings from the natural and social sciences and weaves these understandings into a narrative that reaches from the earliest evidence of malaria infections in tropical Africa up to the present. Written in a style that is easily accessible to non-specialists, it considers the significance of genetic mutations, diet, lifestyle, migration, warfare, palliative and curative... |
![GIANTmicrobes: Malaria (Plasmodium Falciparum) [Toy] [Toy] [Toy]](http://ecx.images-amazon.com/images/I/21rpOp-8iXL._SL160_.jpg) |
GIANTmicrobes: Malaria (Plasmodium Falciparum) [Toy] [Toy] [Toy] by Giant Microbes The tropics have coconuts, soft beaches, clear water, shiny fish, colorful birds, steel drums, umbrella drinks ... and Malaria. Now you can collect a dozen of the most adorable viruses, bacteria, mites, worms and calamities nature ever unleashed. Disturbingly cuddly, Giant Microbes are great learning tools for parents and educators, amusing gifts for anyone with a sense of humor, or just friendly plush companions for those trying to get past their Bacillophobia. Each 5-to-7 inch doll is accompanied by an image of the not-so-cute real microbe it represents, as well as quick facts about the microbe. Antibiotics not required. |
 |
First Comes Love, Then Comes Malaria: How a Peace Corps Poster Boy Won My Heart and a Third World Adventure Changed My Life by Eve Brown-Waite (Author) In this laugh-out-loud funny memoir, a pampered city girl falls head over little black heels in love with a Peace Corps poster boy and follows him —literally–to the ends of the earth. Eve Brown always thought she would join the Peace Corps someday, although she secretly worried about life without sushi, frothy coffee drinks and air conditioning. But with college diploma in hand, it was time to put up or shut up. So with some ambivalence she arrives at the Peace Corps office–sporting her best safari chic attire –to casually look into the steps one might take if one were to become a global humanitarian, a la Angelina Jolie. But when Eve meets John, her dashing young Peace Corps recruiter, all her ambivalence flies out the window. She absolutely must join the Peace Corps -... |
 |
Malaria: Fever Wars Starring: Artist Not Provided |
 |
Sea to Summit Mozi Mosquito Net Shelter,Single by Sea to Summit An indispensable item for traveling or backpacking in bug infested regions. Our Mosquito Net shelters are small, light and compact. They come with a handy stuff sack for easing packing and offer tuck-in sides offer extra protection. |
 |
Molecular Approaches to Malaria by Irwin W. Sherman (Editor) "Molecular Approaches to Malaria" provides an overview of the rapid and significant developments that have occurred in malaria research, including the 2002 genome sequencing of Plasmodium falciparum and its mosquito vector, Anopheles gambiae. This work: provides a concise source of up-to-date research findings; appeals to a diverse audience, including malaria researchers, teachers, investigators, and public health professionals; offers contributions by recognized malaria researchers with practical experience; and, presents comprehensive coverage of topics including a clearly written introduction to Plasmodium molecular biology. |
 |
Revisited by Malaria! |
| © 2009 BrightSurf.com |